首页   按字顺浏览 期刊浏览 卷期浏览 Smoking‐induced coronary vasoconstriction in patients with atherosclerotic coron...
Smoking‐induced coronary vasoconstriction in patients with atherosclerotic coronary artery diseaseevidence for adrenergically mediated alterations in coronary artery tone

 

作者: MICHAEL WINNIFORD,   KEVIN WHEELAN,   MARK KREMERS,   VALENTINA UGOLINI,   EGERTON BERG,   ELAINE NIGGEMANN,   DONALD JANSEN,   DAVID HILLIS,  

 

期刊: Circulation  (OVID Available online 1986)
卷期: Volume 73, issue 4  

页码: 662-667

 

ISSN:0009-7322

 

年代: 1986

 

出版商: OVID

 

数据来源: OVID

 

摘要:

ABSTRACTIn patients with atherosclerotic coronary artery disease, cigarette smoking increases myocardial oxygen demand but may cause an inappropriate decrease in coronary blood flow and myocardial oxgyen supply. This study was performed to explore the mechanism of smoking-induced coronary vasoconstriction and, specifically, to determine if smoking causes an ct-adrenergically mediated increase in coronary artery tone. In 36 chronic smokers with coronary artery disease (27 men and nine women, 50 9 [mean + SD] years old), heart rate-systolic arterial pressure double product and coronary sinus blood flow (by thermodilution) were measured before and during smoking both before and after (1) normal saline (n = 5, control subjects), (2) an at-adrenergic-blocking agent, phentolamine, 5 mg (n 15), (3) a /3-adrenergic-blocking agent, propranolol, 0.1 mg/kg (n = 12), or (4) sodium nitroprusside, 0.4 to 0.8 g.g/kg/min, given in a dose sufficient to diminish systolic arterial pressure by 15% (n 4). During the initial smoking period, rate-pressure product increased and coronary sinus blood flow was unchanged by smoking in all groups. After 30 to 75 min, saline, phentolamine, propranolol, or sodium nitroprusside was given, and measurements were repeated. In the control subjects, rate-pressure product and coronary sinus blood flow responded in a similar manner to that observed previously. In those receiving phentolamine, rate-pressure product was unchanged, but coronary sinus blood flow rose substantially with smoking (percent change + 2 + 15% during the first smoking period [before phentolamine] and +32 + 17% during the second smoking period [after phentolamine]; p <.01). In the 12 patients who received propranolol, rate-pressure product was unchanged, but coronary sinus blood flow fell with smoking (percent change + 5 + 14% during the first smoking period [before propranolol], -12 + 5% during the second smoking period [after propranolol]; p <.01). In those who received sodium nitroprusside, rate-pressure product fell slightly, and coronary sinus blood flow responded in a similar manner to that observed previously. Thus, smoking-induced coronary vasoconstriction is due to an ca-adrenergically mediated increase in coronary artery tone.

 

点击下载:  PDF (1010KB)



返 回